M. Del Vecchio

1.3k total citations
12 papers, 713 citations indexed

About

M. Del Vecchio is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, M. Del Vecchio has authored 12 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Genetics. Recurrent topics in M. Del Vecchio's work include Breast Cancer Treatment Studies (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and CAR-T cell therapy research (3 papers). M. Del Vecchio is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and CAR-T cell therapy research (3 papers). M. Del Vecchio collaborates with scholars based in Italy, France and Australia. M. Del Vecchio's co-authors include Umberto Veronesi, Roberto Saccozzi, B Salvadori, Luigi Mariani, Stefano Zurrida, Marco Greco, Franco Rilke, Alberto Luini, R Zucali and Gabriel Farante and has published in prestigious journals such as British Journal of Cancer, Annals of Oncology and European Journal of Cancer.

In The Last Decade

M. Del Vecchio

11 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Del Vecchio Italy 6 545 340 271 237 95 12 713
Gabriel Farante Italy 10 506 0.9× 332 1.0× 236 0.9× 175 0.7× 164 1.7× 23 683
Patrick Whitworth United States 7 710 1.3× 436 1.3× 430 1.6× 436 1.8× 78 0.8× 10 944
Amy Cyr United States 16 420 0.8× 281 0.8× 178 0.7× 246 1.0× 39 0.4× 46 607
Sabine Pöstlberger Austria 7 385 0.7× 207 0.6× 288 1.1× 104 0.4× 106 1.1× 10 502
F. O’Malley Canada 6 332 0.6× 209 0.6× 223 0.8× 136 0.6× 28 0.3× 9 476
Lee J. McGhan United States 11 308 0.6× 226 0.7× 153 0.6× 166 0.7× 58 0.6× 18 579
J. P. Costantino United States 14 801 1.5× 398 1.2× 541 2.0× 194 0.8× 136 1.4× 39 1.1k
A. Helen Westenberg Netherlands 11 334 0.6× 189 0.6× 220 0.8× 179 0.8× 38 0.4× 19 520
R Collins Hong Kong 3 497 0.9× 220 0.6× 256 0.9× 169 0.7× 57 0.6× 3 682
Gianluca Riboldi Italy 7 317 0.6× 194 0.6× 178 0.7× 152 0.6× 55 0.6× 10 449

Countries citing papers authored by M. Del Vecchio

Since Specialization
Citations

This map shows the geographic impact of M. Del Vecchio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Del Vecchio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Del Vecchio more than expected).

Fields of papers citing papers by M. Del Vecchio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Del Vecchio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Del Vecchio. The network helps show where M. Del Vecchio may publish in the future.

Co-authorship network of co-authors of M. Del Vecchio

This figure shows the co-authorship network connecting the top 25 collaborators of M. Del Vecchio. A scholar is included among the top collaborators of M. Del Vecchio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Del Vecchio. M. Del Vecchio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Arance, Ana, Miguel‐Ángel Berciano‐Guerrero, Jun Guo, et al.. (2025). Randomized, double-blind, phase III LEAP-003 study of first-line lenvatinib plus pembrolizumab versus placebo plus pembrolizumab for unresectable or metastatic melanoma. Annals of Oncology. 36(12). 1535–1546.
2.
Vecchio, M. Del, Christoph Höeller, Jeffrey S. Weber, et al.. (2024). 1077MO Adjuvant nivolumab v placebo in stage IIB/C melanoma: 3-year results from CheckMate 76K. Annals of Oncology. 35. S713–S714. 3 indexed citations
3.
Ascierto, Paolo A., Mario Mandalà, Pier Francesco Ferrucci, et al.. (2020). LBA45 First report of efficacy and safety from the phase II study SECOMBIT (SEquential COMBo Immuno and Targeted therapy study). Annals of Oncology. 31. S1173–S1174. 19 indexed citations
4.
Mandalà, Mario, M. Del Vecchio, Helen Gogas, et al.. (2018). Adjuvant therapy with nivolumab versus ipilimumab after complete resection of stage III/IV melanoma: Updated results from a phase 3 trial (CheckMate 238). British Journal of Cancer. 119(11). 41–42. 1 indexed citations
5.
Meazza, Cristina, Edoardo Farinelli, M. Del Vecchio, et al.. (2007). Growth Hormone Treatment in Prepubertal Children With Celiac Disease and Growth Hormone Deficiency. Journal of Pediatric Gastroenterology and Nutrition. 45(4). 433–437. 18 indexed citations
6.
Veronesi, Umberto, B Salvadori, Marco Greco, et al.. (1995). Breast conservation is a safe method in patients with small cancer of the breast. Long-term results of three randomised trials on 1,973 patients. European Journal of Cancer. 31(10). 1574–1579. 358 indexed citations
7.
Palo, G. De, A. Costa, Franca Formelli, et al.. (1994). Chemoprevention of breast cancer.. PubMed. 7(6B). 577–80. 2 indexed citations
8.
Greco, Marco, Virgilio Sacchini, Roberto Agresti, et al.. (1994). Quadrantectomy is not a disfiguring operation for small breast cancer. The Breast. 3(1). 3–7. 5 indexed citations
9.
Veronesi, Umberto, G. De Palo, A. Costa, et al.. (1992). Chemoprevention of breast cancer with retinoids.. PubMed. 93–7. 40 indexed citations
10.
Veronesi, Umberto, B Salvadori, Alberto Luini, et al.. (1990). Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy.. PubMed. 211(3). 250–9. 259 indexed citations
11.
Colnaghi, Maria I., Roberto Agresti, Sylvie Ménard, et al.. (1988). Monoclonal Antibodies as Prognostic Indicators of Tumor Progression in Breast Cancer. Advances in experimental medicine and biology. 233. 319–327. 4 indexed citations
12.
Veronesi, Umberto, M. Del Vecchio, Alberto Luini, A Rasponi, & R Zucali. (1983). The quadrantectomy, axillary dissection and radiotherapy (QU.A.RT) technique in early breast cancer.. PubMed. 6. 141–65. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabriel Farante Breakdown of academic impact, for papers by Patrick Whitworth Breakdown of academic impact, for papers by Amy Cyr Breakdown of academic impact, for papers by Sabine Pöstlberger Breakdown of academic impact, for papers by F. O’Malley Breakdown of academic impact, for papers by Lee J. McGhan Breakdown of academic impact, for papers by J. P. Costantino Breakdown of academic impact, for papers by A. Helen Westenberg Breakdown of academic impact, for papers by R Collins Breakdown of academic impact, for papers by Gianluca Riboldi
Rankless by CCL
2026